1. Home
  2. KVAC vs FULC Comparison

KVAC vs FULC Comparison

Compare KVAC & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KVAC
  • FULC
  • Stock Information
  • Founded
  • KVAC 2021
  • FULC 2015
  • Country
  • KVAC United States
  • FULC United States
  • Employees
  • KVAC N/A
  • FULC N/A
  • Industry
  • KVAC
  • FULC Biotechnology: Pharmaceutical Preparations
  • Sector
  • KVAC
  • FULC Health Care
  • Exchange
  • KVAC Nasdaq
  • FULC Nasdaq
  • Market Cap
  • KVAC 212.1M
  • FULC 213.6M
  • IPO Year
  • KVAC 2023
  • FULC 2019
  • Fundamental
  • Price
  • KVAC $11.10
  • FULC $3.83
  • Analyst Decision
  • KVAC
  • FULC Hold
  • Analyst Count
  • KVAC 0
  • FULC 9
  • Target Price
  • KVAC N/A
  • FULC $7.63
  • AVG Volume (30 Days)
  • KVAC 4.9K
  • FULC 515.1K
  • Earning Date
  • KVAC 01-01-0001
  • FULC 02-25-2025
  • Dividend Yield
  • KVAC N/A
  • FULC N/A
  • EPS Growth
  • KVAC N/A
  • FULC N/A
  • EPS
  • KVAC 0.43
  • FULC N/A
  • Revenue
  • KVAC N/A
  • FULC $80,871,000.00
  • Revenue This Year
  • KVAC N/A
  • FULC $2,823.78
  • Revenue Next Year
  • KVAC N/A
  • FULC N/A
  • P/E Ratio
  • KVAC $25.73
  • FULC N/A
  • Revenue Growth
  • KVAC N/A
  • FULC 2987.86
  • 52 Week Low
  • KVAC $10.37
  • FULC $2.86
  • 52 Week High
  • KVAC $11.10
  • FULC $13.70
  • Technical
  • Relative Strength Index (RSI)
  • KVAC 85.21
  • FULC 39.01
  • Support Level
  • KVAC $10.94
  • FULC $3.86
  • Resistance Level
  • KVAC $11.10
  • FULC $4.24
  • Average True Range (ATR)
  • KVAC 0.00
  • FULC 0.21
  • MACD
  • KVAC 0.00
  • FULC -0.05
  • Stochastic Oscillator
  • KVAC 90.00
  • FULC 22.90

About KVAC Keen Vision Acquisition Corporation

Keen Vision Acquisition Corp is a blank check company.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

Share on Social Networks: